Adam Maeder
Stock Analyst at Piper Sandler
(3.56)
# 854
Out of 4,941 analysts
93
Total ratings
47.62%
Success rate
7.12%
Average return
Main Sectors:
Stocks Rated by Adam Maeder
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INSP Inspire Medical Systems | Maintains: Overweight | $233 → $150 | $87.39 | +71.64% | 15 | Aug 5, 2025 | |
| RMD ResMed | Maintains: Neutral | $248 → $270 | $289.24 | -6.65% | 4 | Aug 1, 2025 | |
| EW Edwards Lifesciences | Maintains: Overweight | $83 → $90 | $77.73 | +15.79% | 16 | Jul 25, 2025 | |
| ISRG Intuitive Surgical | Reiterates: Overweight | $575 → $595 | $481.98 | +23.45% | 20 | Jul 23, 2025 | |
| RXST RxSight | Maintains: Neutral | $18 → $10 | $8.28 | +20.77% | 2 | Jul 9, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $3.5 → $4 | $4.26 | -6.10% | 1 | Jun 18, 2025 | |
| NSPR InspireMD | Maintains: Overweight | $4.5 → $4 | $2.48 | +61.29% | 4 | May 12, 2025 | |
| TCMD Tactile Systems Technology | Downgrades: Neutral | $25 → $14 | $12.76 | +9.72% | 3 | May 6, 2025 | |
| ABT Abbott Laboratories | Reiterates: Overweight | $133 → $145 | $129.56 | +11.92% | 3 | Apr 17, 2025 | |
| RBOT Vicarious Surgical | Maintains: Neutral | $11 → $8.5 | $9.11 | -6.70% | 7 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $20 → $21 | $13.08 | +60.61% | 2 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $7 → $8 | $3.91 | +104.60% | 1 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $20 | $6.26 | +219.49% | 8 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $5 | $2.65 | +88.68% | 2 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $10 → $18 | $1.61 | +1,018.01% | 2 | Jan 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $104 → $99 | $51.73 | +91.38% | 3 | May 5, 2022 |
Inspire Medical Systems
Aug 5, 2025
Maintains: Overweight
Price Target: $233 → $150
Current: $87.39
Upside: +71.64%
ResMed
Aug 1, 2025
Maintains: Neutral
Price Target: $248 → $270
Current: $289.24
Upside: -6.65%
Edwards Lifesciences
Jul 25, 2025
Maintains: Overweight
Price Target: $83 → $90
Current: $77.73
Upside: +15.79%
Intuitive Surgical
Jul 23, 2025
Reiterates: Overweight
Price Target: $575 → $595
Current: $481.98
Upside: +23.45%
RxSight
Jul 9, 2025
Maintains: Neutral
Price Target: $18 → $10
Current: $8.28
Upside: +20.77%
Sight Sciences
Jun 18, 2025
Maintains: Neutral
Price Target: $3.5 → $4
Current: $4.26
Upside: -6.10%
InspireMD
May 12, 2025
Maintains: Overweight
Price Target: $4.5 → $4
Current: $2.48
Upside: +61.29%
Tactile Systems Technology
May 6, 2025
Downgrades: Neutral
Price Target: $25 → $14
Current: $12.76
Upside: +9.72%
Abbott Laboratories
Apr 17, 2025
Reiterates: Overweight
Price Target: $133 → $145
Current: $129.56
Upside: +11.92%
Vicarious Surgical
Mar 18, 2025
Maintains: Neutral
Price Target: $11 → $8.5
Current: $9.11
Upside: -6.70%
May 22, 2024
Maintains: Hold
Price Target: $20 → $21
Current: $13.08
Upside: +60.61%
Mar 6, 2024
Reiterates: Overweight
Price Target: $7 → $8
Current: $3.91
Upside: +104.60%
Mar 6, 2024
Maintains: Overweight
Price Target: $15 → $20
Current: $6.26
Upside: +219.49%
Mar 6, 2023
Maintains: Overweight
Price Target: $6 → $5
Current: $2.65
Upside: +88.68%
Jan 6, 2023
Upgrades: Overweight
Price Target: $10 → $18
Current: $1.61
Upside: +1,018.01%
May 5, 2022
Maintains: Overweight
Price Target: $104 → $99
Current: $51.73
Upside: +91.38%